TORREYPINES THERAPEUTICS INC. TPTX (NASDAQd) $ 0.21 Change: +0.02 +9.52% | Volume: 34,583
Sponsored by Click here!

TORREYPINES THR - Fundamental Profile

Company Information

Ticker Symbol: TPTX
Exchange: NASD
Contact Info: 11085 North Torrey Pines Road La Jolla CA 92037 858 623-5665
CEO/President: Neil M. Kurtz M.D.
Industry: Medical - Biomedical / Standard Industry Code: 2834
Description: Axonyx, Inc. is engaged in the business of acquiring and developing novel post-discovery central nervous system drug candidates, primarily in areas of memory and cognition. The company acquires patent rights to central nervous system pharmaceutical compounds with potential market impact and advance the compounds through clinical development towards regulatory approval. The company has acquired worldwide exclusive patent rights to three main classes of therapeutic compounds designed for the treatment of Alzheimer\'s Disease, Mild Cognitive Impairment, and related diseases.

Share Information

Shares Outstanding: 15,750 (000) Market Value: 2,530 ($000)
Percentage of Inst.Shareholders: 19.61% Number of Inst.Shareholders: 43.50%
Last Quarter Sales: 1.22 ($Mil.) Last Quarter Net Income: -5.39 ($Mil.)
Last Quarter EPS: -0.34 P/E Ratio: 0
Most Recent Earnings: Earnings Per Share: -1.58
Most Recent Split: Annual Dividend Rate: 0
Most Recent Dividend: Annual Dividend Yield: 0%
Data Provided By Barchart.com
CoreData does not represent, warrant, or guarantee completeness, accuracy or timeliness of its data, and shall have no liability of any kind whatsoever to any party on account of any incompleteness of, inaccuracies in or untimeliness of the CoreData content provided hereunder, or for any delay in reporting such data. CoreData expressly disclaims all warranties of fitness of the CoreData content or computations and analyses thereof for a particular purpose or use.
advertisement